Mary P Cosimano

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Matthew W. Johnson, Annie Umbricht, R. Griffiths, 2016, Journal of psychopharmacology.

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Matthew W. Johnson, R. Griffiths, A. Garcia-Romeu, 2014, Journal of psychopharmacology.

Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Monnica T. Williams, S. Fischer, J. Tulsky, 2022, Journal of palliative medicine.

My Experience as a Guide in the Johns Hopkins Psilocybin Research Project

Mary P Cosimano, 2014 .

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Matthew W. Johnson, Katherine A. MacLean, R. Griffiths, 2017, Journal of psychopharmacology.

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

Matthew W. Johnson, Alan K. Davis, R. Griffiths, 2020, JAMA psychiatry.

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

Matthew W. Johnson, R. Griffiths, F. Barrett, 2022, Journal of psychopharmacology.

R agonist psilocybin in the treatment of tobacco addiction 2 APilot study of the 5-HT

Matthew W. Johnson, R. Griffiths, A. Garcia-Romeu, 2014 .